Previous Close | 7.84 |
Open | 7.83 |
Bid | 6.00 x 800 |
Ask | 8.93 x 900 |
Day's Range | 7.66 - 7.86 |
52 Week Range | 5.61 - 12.45 |
Volume | |
Avg. Volume | 76,679 |
Market Cap | 489.956M |
Beta (5Y Monthly) | 0.41 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Amryt Pharma (AMYT) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Amryt Pharma PLC Sponsored ADR (AMYT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Amryt Pharma PLC Sponsored ADR (AMYT) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.